Atlas FDA

Amplatzer™ Duct Occluder, Amplatzer™ Duct Occluder II, Amplatzer Piccolo™ Occluder

FDA premarket approval P020024/S069 · decided 2024-10-01

Approval details

PMA number
P020024
Supplement
S069
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Amplatzer™ Duct Occluder, Amplatzer™ Duct Occluder II, Amplatzer Piccolo™ Occluder
Generic name
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Applicant
ABBOTT MEDICAL
Date received
2024-07-22
Decision date
2024-10-01
Days to decision
71 days
Decision code
APPR
Product code
MAE
Advisory committee
Cardiovascular
Expedited review
No
Location
St. Paul, MN
Statement
the addition of Centerpiece Tijuana Mexico as an alternative Ethylene Oxide (EO) sterilization facility for the sterilization of the provided devices in scope approved under the PMA/HDE numbers P000039, P02004, P200049, P120021, P040040, H070005, P190023

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18